Notification report

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Notification on the deliberate release of transgenic potatoes with modified carbohydrate metabolism, Solavista-02

Proposed period of release:
01/01/2004 to 31/12/2013

Name of the Institute(s) or Company(ies)
Solavista GmbH&CoKG, ;

3. Is the same GMPt release planned elsewhere in the Community?

Has the same GMPt been notified elsewhere by the same notifier?

Genetically modified plant

Complete name of the recipient or parental plant(s)
Common NameFamily NameGenusSpeciesSubspeciesCultivar/breeding line
potatosolanaceaesolanumsolanum tuberosumtuberosumAveka, Festien

2. Description of the traits and characteristics which have been introduced or modified, including marker genes and previous modifications:
-modified carbohydrate metabolism
-resistance to L-phosphinothricine

Genetic modification

3. Type of genetic modification:

In case of insertion of genetic material, give the source and intended function of each constituent fragment of the region to be inserted:
Left and right T-DNA border: source A. tumefaciens, required for
T-DNA transfer
35 S promotor region: source CaMV, constitutive expression of the bar gene
bar gene Streptomyces hygroscopicus, confers resistance to L-phosphinothricine
ocs- and nos terminator: source A. tumefaciens, termination of transcription
carbohydrate metabolism genes: source potato, modification of carbohydrate metabolism
B33 patatin promotor: source potato, expression of genes involved in carbohydrate metabolism

6. Brief description of the method used for the genetic modification:
A. tumefaciens mediated gene transfer

7. If the recipient or parental plant is a forest tree species, describe ways and extent of dissemination and specific factors affecting dissemination:
not applicable

Experimental Release

1. Purpose of the release:
-sample production for physical, chemical, biochemical and other analyses
-agronomic performance studies of the GMP
-gain new data on the environmental and health safety of the released GMP

2. Geographical location of the site:
Tarnow, Mecklenburg-Vorpommern

3. Size of the site (m2):
maximal annual trial size in Tarnow: 12.500 m2

4. Relevant data regarding previous releases carried out with the same GM-plant, if any, specifically related to the potential environmental and human health impacts from the release:
not applicable

Environmental Impact and Risk Management

Summary of the potential environmental impact from the release of the GMPts:
The genetically modified plants differ in their starch composition compared to unmodified potato plants. In addition, they contain a gene conferring resistance to L-phosphinothricine. No selective advantage of the GMP in natural environment is expected. The altered starch quality do not lead to any selective advantages. A selective advantage of the GMP can only be observed when a selective herbicide containing L-phosphinothricine as active ingredient is applied. No differences in hybridization potential with wild species, persistence and invasiveness of the GMP, or susceptibility of the GMP to plant pathogens compared to the unmodified predecessor plant are expected. No differences in toxicity and allergenicity of the GMP are expected, because the introduced genes do not possess such potential. No negative effects on non-target organisms resulting from the genetic modification are expected.

Brief description of any measures taken for the management of risks:
Pollen dispersal from the GMP to non-transgenic conventional potatoes is prevented by an isolation distance of at least 10 m to any conventional potato. There are only two wild potato species in Europe, Solanum dulcamara and Solanum nigrum. Both wild species do not hybridise successfully with Solanum tuberosum.

Summary of foreseen field trial studies focused to gain new data on environmental and human health impact from the release:
Field release of the GMP is done to produce enough sample material for physical, chemical, biochemical and other analyses as well as to study agronomic performance of the genetically modified plant. Studies analyzing the environmental and health safety of the GMPs may also be realized.

Final report

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known